Sign in
4

Changes in Ownership

Celldex Therapeutics, Inc. Filed Acc 0001415889-24-015148

SVP OF REGULATORY AFFAIRS sold 38,719 shares at $34.07 ($1,319,156)

  • SVP OF REGULATORY AFFAIRS acquired 33,719 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS 2024-05-30 Option exercise +29,068 $2.78 $80,809 41,162 D
Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS 2024-05-30 Option exercise +2,043 $9.02 $18,421 43,205 D
Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS 2024-05-30 Option exercise +2,608 $10.38 $27,071 45,813 D
Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS 2024-05-30 Sale −38,719 $34.07 $1,319,156 7,094 D
Derivatives
Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS 2024-05-30 Option exercise · Incentive Stock Option (Right to Buy) −29,068 12,732 D
Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS 2024-05-30 Option exercise · Incentive Stock Option (Right to Buy) −2,043 6,289 D
Heath-Chiozzi Margo SVP OF REGULATORY AFFAIRS 2024-05-30 Option exercise · Incentive Stock Option (Right to Buy) −2,608 81,392 D
Open-market sales · 38,719 sh · avg $34.07 · $1,319,156
Loading xslF345X05/form4-06032024_080622.xml…